Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Reis LR, Costa-Rocha IAD, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Costa-Pereira C, Otta DA, Freire LC, Lima SMB, Azevedo AS, Schwarcz WD, Ano Bom APD, Silva AMVD, Souza AF, Castro TDM, Ferroco CLV, Filippis AMB, Nogueira FB, Homma A, Domingues CM, Sousa ESS, Camacho LAB, Maia MLS, Teixeira-Carvalho A, Martins-Filho OA. Reis LR, et al. Among authors: maia mls. Vaccine. 2022 Jan 31;40(5):798-810. doi: 10.1016/j.vaccine.2021.12.029. Epub 2021 Dec 27. Vaccine. 2022. PMID: 34969545
Booster dose after 10 years is recommended following 17DD-YF primary vaccination.
Campi-Azevedo AC, Costa-Pereira C, Antonelli LR, Fonseca CT, Teixeira-Carvalho A, Villela-Rezende G, Santos RA, Batista MA, Campos FM, Pacheco-Porto L, Melo Júnior OA, Hossell DM, Coelho-dos-Reis JG, Peruhype-Magalhães V, Costa-Silva MF, de Oliveira JG, Farias RH, Noronha TG, Lemos JA, von Doellinger Vdos R, Simões M, de Souza MM, Malaquias LC, Persi HR, Pereira JM, Martins JA, Dornelas-Ribeiro M, Vinhas Ade A, Alves TR, Maia Mde L, Freire Mda S, Martins Rde M, Homma A, Romano AP, Domingues CM, Tauil PL, Vasconcelos PF, Rios M, Caldas IR, Camacho LA, Martins-Filho OA. Campi-Azevedo AC, et al. Hum Vaccin Immunother. 2016;12(2):491-502. doi: 10.1080/21645515.2015.1082693. Hum Vaccin Immunother. 2016. PMID: 26360663 Free PMC article.
[For the return of high vaccination coverage].
Homma A, Maia MLS, Azevedo ICA, Figueiredo IL, Gomes LB, Pereira CVDC, Paulo EF, Cardoso DB. Homma A, et al. Among authors: maia mls. Cad Saude Publica. 2023 Apr 7;39(3):e00240022. doi: 10.1590/0102-311XPT240022. eCollection 2023. Cad Saude Publica. 2023. PMID: 37477609 Free article. Portuguese.
A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis.
Mendes-de-Almeida DP, Kehdy FSG, Martins-Gonçalves R, Bokel J, Grinsztejn E, Mouta Nunes de Oliveira P, Maia MLS, Hoagland B, Wagner Cardoso S, Grinsztejn B, Siqueira MM, Kurtz P, Bozza PT, Garcia CC. Mendes-de-Almeida DP, et al. Among authors: maia mls. Front Cardiovasc Med. 2023 May 19;10:1189320. doi: 10.3389/fcvm.2023.1189320. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37351283 Free PMC article.
Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response.
Cerbino-Neto J, Peres IT, Varela MC, Brandão LGP, de Matos JA, Pinto LF, da Costa MD, Garcia MHO, Soranz D, Maia MLS, Krieger MA, da Cunha RV, Camacho LAB, Ranzani O, Hamacher S, Bozza FA, Penna GO. Cerbino-Neto J, et al. Among authors: maia mls. Front Public Health. 2022 Nov 14;10:1017337. doi: 10.3389/fpubh.2022.1017337. eCollection 2022. Front Public Health. 2022. PMID: 36457326 Free PMC article.
Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.
Martins RM, Périssé ARS, Camacho LAB, Leal ML, Maia MLS, Homma A, Jessouroun E. Martins RM, et al. Among authors: maia mls. Braz J Infect Dis. 2021 Nov-Dec;25(6):101652. doi: 10.1016/j.bjid.2021.101652. Epub 2021 Nov 16. Braz J Infect Dis. 2021. PMID: 34793713 Free PMC article. Clinical Trial.
Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.
da Silva AMV, Alvarado-Arnez LE, Azamor T, Batista-Silva LR, Leal-Calvo T, Bezerra OCL, Ribeiro-Alves M, Kehdy FSG, Neves PCDC, Bayma C, da Silva J, de Souza AF, Muller M, de Andrade EF, Andrade ACM, Dos Santos EM, Xavier JR, Maia MLS, Meireles RP, Cuni HN, Sander GB, Picon PD, Matos DCS, Moraes MO. da Silva AMV, et al. Among authors: maia mls. Front Cell Infect Microbiol. 2021 Jul 7;11:656393. doi: 10.3389/fcimb.2021.656393. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34307188 Free PMC article.
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
Bastard P, Michailidis E, Hoffmann HH, Chbihi M, Le Voyer T, Rosain J, Philippot Q, Seeleuthner Y, Gervais A, Materna M, de Oliveira PMN, Maia MLS, Dinis Ano Bom AP, Azamor T, Araújo da Conceição D, Goudouris E, Homma A, Slesak G, Schäfer J, Pulendran B, Miller JD, Huits R, Yang R, Rosen LB, Bizien L, Lorenzo L, Chrabieh M, Erazo LV, Rozenberg F, Jeljeli MM, Béziat V, Holland SM, Cobat A, Notarangelo LD, Su HC, Ahmed R, Puel A, Zhang SY, Abel L, Seligman SJ, Zhang Q, MacDonald MR, Jouanguy E, Rice CM, Casanova JL. Bastard P, et al. Among authors: maia mls. J Exp Med. 2021 Apr 5;218(4):e20202486. doi: 10.1084/jem.20202486. J Exp Med. 2021. PMID: 33544838 Free PMC article.
Vaccine failures: assessing yellow fever, measles, varicella, and mumps vaccines.
Petraglia TCMB, Farias PMCM, Sá GRSE, Santos EMD, Conceição DAD, Maia MLS. Petraglia TCMB, et al. Among authors: maia mls. Cad Saude Publica. 2020 Nov 2;36Suppl 2(Suppl 2):e00008520. doi: 10.1590/0102-311X00008520. eCollection 2020. Cad Saude Publica. 2020. PMID: 33146313 Free article. English, Portuguese.
23 results